................................ .....43 Abbreviated Title: Ad5 -based combination vaccines Version Date: 05.16.2018 6 6.3.3 Methods for Evaluation of Measurable Disease ................................ ......................... 44 6.3.4 RECIST Response Criteria ................................ ................................ ......................... 46 6.3.5 Target Response ................................ ................................